Efficacy of 99mTc-Ciprofloxacin and 67Ga-Citrate scintigraphy to discriminate infection foci induced by staphylococcus aureus from sterile inflammation induced by carrageenan in rat

Iranian Journal of Nuclear Medicine

Volumn 23, Issue 2, 2015, Pages 96-102

  Doroudi, Alireza ^a   Erfani, Mostafa ^b   Kooshki, Fatemeh ^a   Saadati, Seyyed Mostafa ^c   Ahmadi, Farzad ^c   Kiasat, Ali ^c   Khodayar, Mohammad Javad ^a   Etessami, Behrooz ^c   Meghdadi, Hossein ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

67Ga; 99mTc Ciprofloxacin; Carrageenan

Indexed keywords

CARRAGEENAN; CIPROFLOXACIN; CIPROFLOXACIN TC 99M; CITRATE CALCIUM GA 67; CITRIC ACID; DNA TOPOISOMERASE (ATP HYDROLYSING); RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INFLAMMATION; ISOTOPE LABELING; MALE; NONHUMAN; PREDICTIVE VALUE; QUALITY CONTROL; RAT; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 84938149934     PISSN: 16812824     EISSN: 20082509     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J, Das S. Clinical evaluation of technetium- 99m infecton for the localisation of bacterial infection. Eur J Nucl Med. 1997 May;24(5):553-6
2. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med. 1994 Apr;24(2):128-41
3. Crerand S, Dolan M, Laing P, Bird M, Smith ML, Klenerman L. Diagnosis of osteomyelitis in neuropathic foot ulcers. J Bone Joint Surg Br. 1996 Jan;78(1):51-5
4. Bohchelian HA, Klisarova AD, Koeva LA. Radioimmune imaging of diabetic foot infection - Tc- 99m-labelled antigranulocyte antibody in combination with Tc-99m-methylene diphosphonate bone scintigraphy. Turk J Med Sci. 2002;32:255-59
5. Weiner RE, Thakur ML. Radiolabeled peptides in diagnosis and therapy. Semin Nucl Med. 2001 Oct;31(4):296-311
6. Mirshojaei SF, Gandomkar M, Najafi R, Sadat Ebrahimi SE, Babaei MH, Shafiei A, Talebi MH. Radio labeling, quality control and biodistribution of 99m Tc-cefotaxime as an infection imaging agent. J Radioanal Nucl Chem . 2011;287:21-25
7. Shah SQ, Rafiullah Khan M. Radiocharacterization of the 99m Tc-rufloxacin complex and biological evaluation in Staphylococcus aureus infected rat model. J Radioanal Nucl Chem. 2011;288:373-78
8. Motaleb MA. Preparation and biodistribution of 99m Tc-lomefloxacin and 99m Tc-ofloxacin complexes. J Radioanal Nucl Chem. 2007;272:95-99
9. Benitez A, Roca M, Martin-Comin J. Labeling of antibiotics for infection diagnosis. Q J Nucl Med Mol Imaging. 2006 Jun;50(2):147-52
10. Erfani M, Doroudi A, Hadisi L, Andishmand A, Mirshojaei SF, Shafiei M. (99m) Tc-tricabonyl labeling of ofloxacin and its biological evaluation in Staphylococcus aureus as an infection imaging agent. J Labelled Comp Radiopharm. 2013 Oct;56(12):627-31
11. Erfani M , Doroudi A, Hadisi L, Andishmand A, Mazidi SM. Optimization condition in labeling of Ofloxacin with 99mTc and its biological evaluation in Staphylococcus aureus and Escherichia coli for infection imaging. Iran J Nucl Med. 2013;21(1):1-6
12. Fuster D, Soriano A, Garcia S, Piera C, Suades J, Rodríguez D, Martinez JC, Mensa J, Campos F, Pons F. Usefulness of 99mTc-ciprofloxacin scintigraphy in the diagnosis of prosthetic joint infections. Nucl Med Commun. 2011 Jan;32(1):44-51
13. Yapar Z, Kibar M, Yapar AF, Toʇrul E, Kayaselçuk U, Sarpel Y. The efficacy of technetium-99m ciprofloxacin (Infecton) imaging in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging. Eur J Nucl Med. 2001 Jul;28(7):822-30
14. Singh B, Mittal BR, Bhattacharya A, Aggarwal A, Nagi ON, Singh AK. Technetium-99m ciprofloxacin imaging in the diagnosis of postsurgical bony infection and evaluation of the response to antibiotic therapy: A case report. J Orthop Surg (Hong Kong). 2005 Aug;13(2):190-4
15. Hall AV, Solanki KK, Vinjamuri S, Britton KE, Das SS. Evaluation of the efficacy of 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol. 1998 Mar;51(3):215-9
16. Thomson AW, Fowler EF. Carrageenan: a review of its effects on the immune system. Agents Actions. 1981 May;11(3):265-73
17. Britton KE, Wareham DW, Das SS, Solanki KK, Amaral H, Bhatnagar A, Katamihardja AH, Malamitsi J, Moustafa HM, Soroa VE, Sundram FX, Padhy AK. Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton). J Clin Pathol. 2002 Nov;55(11):817-23
18. Sarda L, Crémieux AC, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, Génin R, Delahaye N, Huten D, Le Guludec D. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003 Jun;44(6):920-6
19. Sugishita E, Amagaya S, Ogihara Y. Anti-inflammatory testing methods: comparative evaluation of mice and rats. J Pharmacobiodyn. 1981 Aug;4(8):565-75
20. Henriques MG, Silva PM, Martins MA, Flores CA, Cunha FQ, Assreuy-Filho J, Cordeiro RS. Mouse paw edema. A new model for inflammation? Braz J Med Biol Res. 1987;20(2):243-9
21. Petersson M, Wiberg U, Lundeberg T, Uvnäs-Moberg K. Oxytocin decreases carrageenan induced inflammation in rats. Peptides. 2001 Sep;22(9):1479-84
22. Cuzzocrea S, Sautebin L, De Sarro G, Costantino G, Rombolà L, Mazzon E, Ialenti A, De Sarro A, Ciliberto G, Di Rosa M, Caputi AP, Thiemermann C. Role of IL- 6 in the pleurisy and lung injury caused by carrageenan. J Immunol. 1999 Nov 1;163(9):5094-104
23. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PT, Currie MG. Nitric oxide: a key mediator in the early and late phase of carrageenaninduced rat paw inflammation. Br J Pharmacol. 1996 Jun;118(4):829-38
24. Love C, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Technol. 2004 Jun;32(2):47-57
25. Rodriguez-puig D, Piera C, Fuster D, Soriano A, Sierra JM, Rubi S, Saudes J. A new method of [99mTc]- ciprofloxacin preparation and quality control. J Labelled Comp Radiopharm. 2006;49(13):1171-1176
26. Easmon CS, Crane JP, Blowers A. Effect of ciprofloxacin on intracellular organisms: in-vitro and invivo studies. J Antimicrob Chemother. 1986 Nov;18 Suppl D:43-8